Revision history of "Introduction to the Applicant’s offer of a new product – food for special medical purposes for patients with osteoarthritis." (Q2687083)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

8 October 2024

  • curprev 21:4921:49, 8 October 2024DG Regio talk contribs 69,295 bytes +8 Changed label, description and/or aliases in pt
  • curprev 21:4921:49, 8 October 2024DG Regio talk contribs 69,287 bytes +14 Set a claim value: summary (P836): SA 42799(2015/X) O projeto faz parte da estratégia a longo prazo da empresa e consiste na continuação da implementação dos resultados do trabalho de I & D anteriormente encomendado à Unidade Científica, que é o Instituto Farmacêutico de Varsóvia e que consiste no desenvolvimento e exame de um dispositivo significativamente melhorado para doentes com osteoartrite. O objetivo do investimento é implementar na oferta comercial um produto que terá não só...

23 March 2024

12 January 2024

14 June 2023

11 June 2023

24 May 2023

2 March 2023

  • curprev 20:3920:39, 2 March 2023DG Regio talk contribs 66,512 bytes +241 Changed label, description and/or aliases in da, it, lv, bg, sk, el, fr, ro, et, sl, pt, ga, fi, cs, sv, es, de, hu, hr, lt, nl, mt, and other parts

20 October 2022

10 July 2022

  • curprev 10:3410:34, 10 July 2022DG Regio talk contribs 65,450 bytes +41,242 Changed label, description and/or aliases in da, el, hr, ro, sk, mt, pt, fi, sl, cs, lt, lv, bg, hu, ga, sv, et, nl, fr, de, it, pl, es, and other parts: Adding translations: da, el, hr, ro, sk, mt, pt, fi, sl, cs, lt, lv, bg, hu, ga, sv, et,

19 January 2022

15 January 2022

17 December 2021

13 December 2021

3 December 2021

21 September 2021

25 July 2021

7 July 2021

  • curprev 12:1612:16, 7 July 2021DG Regio talk contribs 12,287 bytes +188 Changed label, description and/or aliases in en: translated_label
  • curprev 12:1612:16, 7 July 2021DG Regio talk contribs 12,099 bytes +2,004 Created claim: summary (P836): SA 42799(2015/X) The project is part of the Company’s long-term strategy and consists of further implementation of the results of R & D work previously commissioned to the Scientific Unit, which is the Pharmaceutical Institute in Warsaw and consisting of developing and examining a significantly improved device for patients with osteoarthritis. The purpose of the investment is to implement into the sales offer a product that will have not only a...

21 May 2021

20 May 2021